A Redox‐Responsive β‐Glucan‐Based Vaccine Recruiting Endogenous Antibodies to Potentiate Antifungal Immunity
Chemistry – A European Journal · 27.05.2026 · 32 (20)
DOI: 10.1002/chem.202503568 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, online erschienen am 12.03.2026. Verfasst von Zhifang Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Key Laboratory of Carbohydrate Chemistry & Biotechnology, School of Biotechnology, Ministry of Education, Jiangnan University, Wuxi, China. Hauptthemen laut MEDLINE: Candida albicans, beta-Glucans, Fungal Vaccines, Antibodies, Fungal. Die Arbeit nennt 36 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Social Development Key Project of Jiangsu Province.
Abstract (Originalsprache)
Invasive fungal infections caused by Candida albicans pose a serious threat to human health, particularly in immunocompromised individuals. Surface‐exposed β‐glucans of C. albicans have been identified as promising targets for antifungal vaccine development. However, conventional glycoconjugate vaccines often suffer from limited immunogenicity. Herein, we report an innovative vaccine strategy that recruits endogenous antibodies, such as anti‐rhamnose (Rha) antibodies, to improve antigen delivery to antigen‐presenting cells (APCs). A redox‐responsive disulfide linker was incorporated into the vaccine design to promote endosomal escape and enhance antigen processing. The construct was prepared by conjugating β‐glucans to bovine serum albumin (BSA), followed by coupling Rha haptens via the redox‐responsive linker, yielding β‐glucans‐BSA‐L2‐Rha. Immunological evaluations demonstrated that the presence of endogenous anti‐Rha antibodies substantially enhanced immune responses, with the redox‐responsive glycoconjugate eliciting the strongest reactivity. Moreover, antisera generated by the vaccine effectively recognized the hyphal form of heat‐killed C. albicans (HKCA). This study establishes a broadly applicable strategy for the further development of antifungal vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Key Laboratory of Carbohydrate Chemistry & Biotechnology, School of Biotechnology, Ministry of Education, Jiangnan University, Wuxi, China.
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Social Development Key Project of Jiangsu Province
- the Open Foundation of Key Laboratory of Carbohydrate Chemistry & Biotechnology, Ministry of Education, China
- 111 Project
- National Key Research and Development Program of China
Zitieren
APA
Zhou, Z., Qu, M., Lin, H., Li, M., Wang, P., Ding, J., He, Y., Shi, J., & Wu, Z. (2026). A Redox‐Responsive β‐Glucan‐Based Vaccine Recruiting Endogenous Antibodies to Potentiate Antifungal Immunity. Chemistry – A European Journal, 32(20). https://doi.org/10.1002/chem.202503568
Vancouver
Zhou Z, Qu M, Lin H, Li M, Wang P, Ding J, et al. A Redox‐Responsive β‐Glucan‐Based Vaccine Recruiting Endogenous Antibodies to Potentiate Antifungal Immunity. Chemistry – A European Journal. 2026;32(20). doi:10.1002/chem.202503568
BibTeX
@article{Zhou2026,
author = {Zhou, Zhifang and Qu, Mengyuan and Lin, Han and Li, Mingyu and Wang, Peirui and Ding, Jingyi and He, Yanlin and Shi, Jie and Wu, Zhimeng},
title = {A Redox‐Responsive β‐Glucan‐Based Vaccine Recruiting Endogenous Antibodies to Potentiate Antifungal Immunity},
journal = {Chemistry – A European Journal},
year = {2026},
volume = {32},
number = {20},
doi = {10.1002/chem.202503568}
}
EUVIMED